Importance of diabetes genetic variants unclear

April 4, 2012
Importance of diabetes genetic variants unclear

(HealthDay) -- Genetic variants associated with type 2 diabetes that affect glucagon-like peptide 1 (GLP-1) are not associated with GLP-1 levels or GLP-1-induced insulin secretion in healthy individuals, according to a study published online March 28 in Diabetes.

To validate the observed effects of disease-associated variants in the TCF7L2, WFS1, and KCNQ1 genes on GLP-1, Galina Smushkin, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues examined GLP-1 levels and responses in healthy subjects.

The researchers found no association between the presence of the variants and GLP-1 concentrations in response to an oral glucose challenge. There was also no apparent effect on β-cell responsiveness to hyperglycemia and GLP-1 infusion. A diabetes-associated variant in TCF7L2 did significantly affect the ability of hyperglycemia to suppress .

"The results of these experiments contrast with prior (similarly powered) reports that TCF7L2 and WFS1 alter β-cell responsiveness to infused GLP-1 and that variants in KCNQ1 alter GLP-1 concentrations after an oral challenge in nondiabetic humans," Smushkin and colleagues conclude. "While far from conclusive, these results highlight the importance of independent replication prior to concluding that a given genotype has a particular effect on a complex phenotype."

One author disclosed financial relationships with Merck, Sanofi-Aventis, and Bristol-Myers Squibb.

Explore further: Research reveals hormone action that could lead to treatments for type 2 diabetes

More information: Abstract
Full Text (subscription or payment may be required)


Related Stories

Bile acids may hold clue to treat heart disease

December 6, 2011

Heart disease is a major cause of death in industrialised countries, and is strongly associated with obesity and diabetes. Many scientists believe that what links these conditions is a chronic, low-grade inflammation. The ...

Improving psoriasis with GLP-1 analogue therapy

December 13, 2011

(Medical Xpress) -- UCD clinician scientists and researchers from NUI Maynooth and Trinity College led by Conway Fellow, Professor Donal O’Shea have reported an improvement in the severity of psoriasis in patients following ...

Recommended for you

Engineered hot fat implants reduce weight gain in mice

August 20, 2015

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose ...

Promising progress for new treatment of type 1 diabetes

July 30, 2015

New research from Uppsala University shows promising progress in the use of anti-inflammatory cytokine for treatment of type 1 diabetes. The study, published in the open access journal Scientific Reports, reveals that administration ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.